Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Marie Skłodowska-Curie Action · Running

TEaR-flu Tfh determinants for effective responses to influenza vaccination in older individuals

Coordinator
Fundacao Gimm - Gulbenkian Institute for Molecular Medicine, Portugal
Runs
1 June 2026 to 31 May 2028
Status
Running
EU funding
€207k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101334370

What the project is doing

In the project's own words, from its summary on CORDIS.

Seasonal influenza causes significant morbidity and mortality each year, especially among older adults. This is due to reduced vaccine efficacy in this group. Indeed, despite vaccination efforts, many individuals in this age range remain unprotected, highlighting the urgent need to identify factors that influence effective immune responses. This project, TEaR-flu, focuses on antigen-specific T follicular helper (Tfh) cells, the specialised T cell subset that provides help to B cells, to uncover molecular and cellular features that differentiate older individuals who mount strong (high responders, HR) from those who mount weak (low responders, LR) responses to influenza vaccination.

Leveraging a large clinical cohort (~300 older individuals) that will be collected before the start of this proposal, I will stratify participants based on serological responses and perform single-cell transcriptomics and TCR repertoire sequencing on influenza-specific T cells from 40 selected HR and LR individuals. Using computational analyses, I will then identify transcriptional programs and TCR motifs that differ between HR and LR and, consequently, are linked to vaccine immunogenicity.

Findings will be validated in silico, using publicly available datasets, and functionally tested in human tonsil organoids, providing mechanistic insights into the drivers of vaccine responsiveness. Finally, a model for vaccine immunogenicity will be developed, considering not only the transcriptional differences but also clinical data from the cohort volunteers. All together, TEaR-flu is a highly interdisciplinary proposal that combines immunology, single-cell genomics, computational biology, and organoid models to generate predictive models of vaccine immunogenicity and identify potential targets for improved vaccine efficacy and new vaccine strategies.

Topics

Who is involved

OrganisationCityCountryRole
Fundacao Gimm - Gulbenkian Institute for Molecular MedicineLisboaPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI